Ultra-Scan Corporation is an acknowledged leader in the field of high-accuracy fingerprint identification.  A privately held corporation based in Amherst, New York, the Company has more than 15 years experience designing, developing, manufacturing and selling its unique technology and products to government, commercial and industrial customers around the world.

The Company holds an extensive portfolio of patents pertaining to ultrasonic fingerprint identification.  The US Department of Justice, Department of Defense and New York State itself have repeatedly turned to Ultra-Scan to undertake research and development projects aimed at major performance improvements in fingerprints and other biometric technology.  

Ultra-Scan pioneered the use of ultrasonic imaging to achieve superior system accuracy.  It currently leads the industry in accuracy, usability, and enrollability for real world identity management solutions.  Some relevant operational installations include methadone treatment patient identification in Western NY, patient ID for hospitals, access control for the New York State Office of Public Security, John F. Kennedy and LaGuardia airports and commercial truck driver outdoor identification in Canada and the US Midwest.

Ultra-Scan has deployed biometric Enterprise Master Patient Indexing (EMPI) systems for the Catholic Health System, which links electronic health records to the patient’s fingerprint data, and thus, eliminating medical record errors.  The EMPI system has gained much attention withing the healthcare industry and is now in various stages of implementation with leading health systems across the United States.  Ultra-Scan Corporation has also worked with the Drug Enforcement Agency (DEA) and the Ohio State Board of Pharmacy in developing a solution to meet requirements for positive identification of healthcare professionals authorizing perscriptions.  

Within the biometrics community, Ultra-Scan has built a solid reputation for superior technology and quality products.